2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




NeuroVascular Quality Initiative Expands With Cerebral Aneurysm and Cerebral AVM Modules

October 8, 2015 -- The Society of NeuroInterventional Surgery (SNIS) and M2S, Inc. recently announced the launch of the Cerebral Aneurysm Module and the Cerebral Arteriovenous…

First Commercial Case Performed With Silk Road Medical’s Enroute Transcarotid Stent System

October 6, 2015 -- Silk Road Medical, Inc. announced the first commercial case in the United States using the company's Enroute transcarotid stent system. Peter A. Schneid…

Study Supports UFE in Fibroids Larger Than 10 cm

October 7, 2015 -- In a study of uterine fibroid embolization published in CardioVascular and Interventional Radiology (CVIR), Viktor Bérczi, MD, et al conclu…

FDA Approves InSightec’s Next-Generation ExAblate Fibroid Treatment System

  October 7, 2015 -- InSightec, an Israel-based manufacturer of magnetic resonance-guided focused ultrasound (MRgFUS) therapy products, announced that the US Food and …

Interim Results Presented for QT Vascular’s Chocolate Touch

October 6, 2015 -- QT Vascular Ltd. announced the release of the interim results from ENDURE, the first study of the company’s Chocolate Touch peripheral drug-coate…

Study Compares Endovascular Intervention and Surgery to Treat Symptomatic Lower Extremity PAD

October 6, 2015 -- Thomas T. Tsai, MD, et al published findings from an evaluation of the contemporary safety and effectiveness of peripheral endovascular interventions compar…

OptiMed’s Sinus-Venous Stent Evaluated in Treatment of Chronic Venous Obstructive Disease

October 6, 2015 -- Mark Antonius Friedrich de Wolf, MD, et al published initial results from an early experience with the sinus-Venous stent (OptiMed GmbH) in the Europea…

Click here for more News coverage

Current Supplement

Sponsored by TRIVASCULAR, INC.

The Patency Issue

Leading EVAR experts highlight the latest technology and strategies to promote long-term limb patency in the most challenging anatomy.

Special Fall Supplement

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $41.16  1.30%
AstraZeneca PLC $32.39  1.47%
Boston Scientific Corporation $16.79  -0.18%
BTG plc $536.50  -1.74%
Cardiovascular Systems Inc. $13.62  -18.10%
CR Bard Inc. $187.02  0.11%
Edwards Lifesciences Corp. $146.27  0.68%
Endologix Inc. $12.91  -0.77%
Hansen Medical, Inc. $4.24  9.00%
Vascular Market Price  Change
Johnson and Johnson $95.08  0.11%
Lombard Medical, Inc. $3.76  -3.09%
Medtronic, Inc. $72.05  1.56%
Merit Medical Systems, Inc. $23.67  -5.21%
St. Jude Medical Inc. $63.19  0.14%
The Medicines Company $34.81  -3.31%
The Spectranetics Corporation $10.91  -7.93%
TriVascular Technologies, Inc. $6.18  0.16%
Vascular Solutions Inc. $32.39  -0.55%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media